retatrutide weight loss chart Retatrutide's Triumph: Lilly's Triple Agonist Redefines Potential Retatrutide hits 28% weight loss

Effects of semaglutide on heart failure outcomes in diabetes and chronic kidney disease in the FLOW trial

Oshis team understands what patients struggling with GI symptoms, including those taking GLP-1s, need: Integrated multidisciplinary care: Patients should receive coordinated care addressing each of their needs, with support from GI providers for diagnosis and medication, registered dietitians to pair GLP-1s with the right diet for sustainable improvement, behavioral health specialists to ease the anxiety around GLP-1 side effects for adherence, and care coordinators to work with their existing GLP-1 provider

Structured lifestyle programmes form the cornerstone of effective weight management

Wegovy Dosage (Semaglutide): Start : 0.25 mg weekly for 4 weeks Titrate : 0.5 mg 1 mg 1.7 mg 2.4 mg Wegovy uses a structured four-step dose increase, with timing recommendations between each level

For people with obesity related OSA, tirzepatide may help sleep rather than harm it